Placeholder Banner

BIO Stands United with the President's Goal of Ending Cancer

February 2, 2022
Media Contact

The following statement can be attributed to BIO's President and CEO Dr. Michelle McMurry-Heath:

“President Biden has long been a champion of research to end cancer. He reaffirmed that commitment today with the relaunch of the "Cancer Moonshot."

"Though details are still forthcoming, BIO welcomes this initiative and stands united with the President's goal of ending the untold human suffering from cancer.

"In the coming weeks, we look forward to working with the White House as it develops a long-term strategy, especially as it relates to understanding the effects of all healthcare policies on the development of future cancer cures."

Discover More
Today, the Biotechnology Innovation Organization (BIO) released a new analysis showing that the current level of investment in new pain and addiction treatments is falling short of what is needed to combat the mounting public health crises. The…
The governments of Mexico, Canada and the United States should look to the framework in the U.S.-Mexico-Canada Agreement to continue growing the complementary trade and integrated markets throughout North America, agriculture-related associations…
VANCOUVER, BC, CANADA, and WASHINGTON, DC, UNITED STATES, Dec. 12, 2022 – Today, Novateur Ventures, a leading global life sciences advisory firm and Biotechnology Innovation Organization (BIO), the world's largest advocacy association for…